A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

NCT01085084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Arthritis

Interventions

DRUG: Laquinimod
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.